India Pharmaceutical Manufacturing 2026Updated

List of GMP-Certified API Manufacturers in India

Name: List of GMP-Certified API Manufacturers in India
Creator: ReqoData

Comprehensive directory of GMP-certified active pharmaceutical ingredient manufacturers across India, with regulatory approvals, therapeutic specializations, and production capacity details for pharmaceutical procurement and supply chain sourcing.

Available Data Fields

Company Name

GMP Certifications

Headquarters Location

Key API Categories

Regulatory Approvals

Export Markets

Production Capacity

Therapeutic Areas

Contact Information

Quality Standards

Data Preview

* Full data requires registration

Company Name	Headquarters	Key Certifications	Key API Categories
Aurobindo Pharma Ltd.	Hyderabad, Telangana	USFDA, WHO-GMP, EU-GMP, PMDA	Antibiotics, Anti-retrovirals, CNS
Dr. Reddy's Laboratories	Hyderabad, Telangana	USFDA, WHO-GMP, MHRA, EMA	Steroids, Peptides, Oncology
Cipla Ltd.	Mumbai, Maharashtra	WHO-GMP, USFDA, TGA	Respiratory, Anti-infectives, Oncology
Laurus Labs Ltd.	Hyderabad, Telangana	USFDA, EMA, WHO-GMP, PMDA	Anti-retrovirals, Oncology, Custom Synthesis
Sun Pharmaceutical Industries	Mumbai, Maharashtra	USFDA, WHO-GMP, MHRA, TGA	Oncology, Dermatology, Cardiology

1,000+ records available for download.

* Continue from free preview

GMP-Certified API Manufacturing in India: A Global Supply Hub

India accounts for approximately 20% of global generic drug production by volume and is home to over 1,500 WHO-GMP certified API manufacturing facilities. The Central Drugs Standard Control Organisation (CDSCO) maintains the official registry of WHO-GMP certified units, with the highest concentration in Gujarat (684 certified units), Maharashtra (229), and Himachal Pradesh (202).

Regulatory Landscape

Indian API manufacturers operate under a multi-layered regulatory framework. Domestic compliance is governed by the Drugs and Cosmetics Act, 1940, enforced by the CDSCO. For export markets, manufacturers pursue certifications from international bodies:

WHO-GMP: Baseline requirement for export to emerging markets; over 1,400 Indian facilities currently certified
USFDA: Required for the US market; India has the highest number of USFDA-approved plants outside the US
EU-GMP / EDQM: Certificate of Suitability (CEP) required for European market access
PMDA (Japan): Growing approval base as Japanese generics market expands

Key Manufacturing Clusters

Region	Specialization	Notable Companies
Hyderabad, Telangana	Bulk APIs, anti-retrovirals, custom synthesis	Dr. Reddy's, Aurobindo, Laurus Labs, MSN Laboratories
Mumbai & Raigad, Maharashtra	Respiratory APIs, oncology intermediates	Cipla, Sun Pharma, Glenmark
Gujarat (Ahmedabad, Vadodara)	Formulation-linked APIs, cardiovascular	Torrent Pharma, Cadila Healthcare
Visakhapatnam, AP	Fermentation-based APIs, large-scale synthesis	Divis Laboratories, Laurus Labs

Market Dynamics

India's API sector has benefited from global supply chain diversification efforts, particularly since 2020, with the Indian government's Production Linked Incentive (PLI) scheme allocating over INR 6,940 crore to boost domestic API production for 53 critical drug intermediates and APIs. This includes key starting materials (KSMs) where India previously depended heavily on Chinese imports.

What Buyers Should Evaluate

When sourcing APIs from Indian manufacturers, procurement teams should verify:

Current GMP status — check CDSCO's WHO-GMP list and the FDA's inspection database for recent audit outcomes
Drug Master File (DMF) filings — active DMFs with the USFDA or CEPs with EDQM indicate export readiness
Capacity and supply reliability — multi-site manufacturers offer redundancy; single-site suppliers carry higher risk
Vertical integration — manufacturers producing from KSMs through to finished APIs reduce supply chain vulnerability

Frequently Asked Questions

Q.How does ReqoData verify that a manufacturer's GMP certification is current?

When you request data, our AI crawls official regulatory databases including the CDSCO WHO-GMP registry, FDA inspection databases, and EDQM CEP listings to retrieve the most current certification status available from public sources.

Q.Can I filter manufacturers by specific API or therapeutic category?

Yes. You can specify therapeutic areas (e.g., oncology, anti-retrovirals, cardiovascular), specific molecules, or API types (e.g., fermentation-based, synthetic) to narrow your results.

Q.Does the data include manufacturers who have received FDA warning letters?

Our data reflects publicly available regulatory records. If a manufacturer has received an FDA warning letter, this information is included since it is published on the FDA's public enforcement database.

Q.Are contract development and manufacturing (CDMO) companies included?

Yes. Many Indian API manufacturers also offer CDMO services. You can filter specifically for companies offering custom synthesis and contract manufacturing alongside their own API portfolio.

Q.What geographic coverage does this dataset have within India?

The dataset covers all major pharmaceutical manufacturing clusters across India, including Hyderabad, Mumbai, Gujarat, Himachal Pradesh, Goa, Visakhapatnam, and other regions where API production is concentrated.